amyloid aggregation-mitigating peptide analogs (Louisiana State University/Louisiana State University Office of Intellectual Property, Commercialization & Development)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameamyloid aggregation-mitigating peptide analogs (Louisiana State University/Louisiana State University Office of Intellectual Property, Commercialization & Development)
Drug Alias Nameamyloid beta protein aggregation inhibitors (Louisiana State University/Louisiana State University Office of Intellectual Property, Commercialization & Development)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLouisiana State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLouisiana State University Office of Intellectual Property, Commercialization & DevelopmentLouisiana State University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A